018188299

---

January 23, 2020

Trademark Summary

The trademark application was filed by Black Diamond Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 15, 2020, and it was registered by office on July 23, 2020 without any oppositions.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical and medical therapeutics and preparations for the treatment of oncological diseases and disorders and Biopharmaceutical products, namely, pharmaceutical preparations for treating oncological diseases and disorders..
• The mark was filed in class 42 with following description of goods:
  
  1. Pharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer
  2. Pharmaceutical research and development services
  3. Research and development services in connection with diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant for treatment with oncology treatments.